[1] Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

[2] Duodenal infusion of donor feces for recurrent Clostridium difficile

[3] Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin

[4] Managing antibiotic use--impact of infection control

[5] Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects

[6] Fidaxomicin versus vancomycin for Clostridium difficile infection